STTK — Shattuck Labs, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1680367 ·
Last close
$4.59
Market Cap
$467.46M
52W High
$8.33
52W Low
$1.88
ADV30
1,050,306
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -27,046,000 -25,203,000 207,975,000 61,758,000 14,313,000
Jun 2026 0 — -16,155,000 -15,152,000 220,667,000 63,299,000 9,531,000
Mar 2026 0 — -15,545,000 -14,767,000 102,121,000 90,419,000 6,286,000
Dec 2025 0 — -13,371,000 -12,593,000 91,026,000 54,192,000 8,636,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-41,028,000
Investing CF
$-144,585,000
Financing CF
$198,445,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.51
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-460,448,000
Inventory
—
Receivables
—
ST Investments
$145,004,000
EBIT TTM
$-55,787,000
Pretax Income TTM
$-52,568,000
Interest Exp TTM
—
Analysts
10

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,000,000
EBITDA
$-52,140,000
Free Cash Flow
$-21,216,624
Enterprise Value
$311,241,760
Total Cash
$208,303,008
Total Debt
$2,674,000
Shares Out
101,842,552
Trailing EPS
$-0.47
Book Value
$1.30
ROE
-39.2%
ROA
-24.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,000,000 -51,508,000 -48,809,000 91,026,000 8,636,000 82,390,000 -39,882,000
Dec 2024 5,721,000 -80,567,000 -75,410,000 91,049,000 11,423,000 79,626,000 -60,515,000
Dec 2023 1,657,000 -91,957,000 -87,298,000 159,564,000 14,859,000 144,705,000 -81,228,000
Dec 2022 652,000 -103,329,000 -101,945,000 205,324,000 29,167,000 176,157,000 -94,498,000

TTM Snapshot

Revenues TTM
$1,000,000
NetIncome TTM
$-52,568,000
OpCashFlow TTM
—
Assets (Latest)
$220,667,000
Forward EPS
$-0.56

Max Pain — expiry 2026-12-18

max pain strike: $5.00 · spot: $4.47 · call oi: 681 · put oi: 3,530

Peers — same industry

TickerNameMarket CapLastDaily %
AQST Aquestive Therapeutics, Inc. $465.04M $3.70 —
KMDA KAMADA LTD $470.92M $8.16 —
AMRN AMARIN CORP PLC\UK $473.82M $11.27 —
ASMB ASSEMBLY BIOSCIENCES, INC. $460.74M $22.50 —
NGNE Neurogene Inc. $478.19M $23.10 —

News headlines (Yahoo Finance, 1h cache)

Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-12 21:05 · Yahoo
Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights
2026-11-05 13:00 · Yahoo
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
2026-10-13 12:00 · Yahoo
Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development
2026-10-01 11:00 · Yahoo
Shattuck Labs Announces Participation in Upcoming September Investor Conferences
2026-09-02 20:05 · Yahoo
What Shattuck Labs Stock Topped the Market on Monday
2026-08-24 22:23 · Yahoo
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
2026-08-13 13:55 · Yahoo
Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights
2026-08-11 10:15 · Yahoo
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
2026-07-24 22:27 · Yahoo
Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update
2026-06-09 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.